Who is sponsoring NCT03489460?

NCT03489460 is sponsored by NYU Langone Health.

What drugs are being tested in NCT03489460?

Interventions in NCT03489460: Specialized sleep-related message interventions, GAD.

What condition does NCT03489460 study?

NCT03489460 studies Sleep Health.

Is NCT03489460 still recruiting?

NCT03489460 is currently completed. Last updated 30 January 2020.

Last reviewed 2020-01-30 · How we verify

NCT03489460: RESET

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Research Exploring Sleep Education & Technology

Completed NA Last updated 30 January 2020

What this trial tests

NA trial testing Specialized sleep-related message interventions in Sleep Health in 1,060 participants. Completed in 1 August 2019.

Timeline

1 February 2019

Primary endpoint
1 August 2019

1 August 2019

Quick facts

Lead sponsor	NYU Langone Health
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	1,060
Start date	1 February 2019
Primary completion	1 August 2019
Estimated completion	1 August 2019
Sites	1 location across United States

Drugs / interventions tested

Specialized sleep-related message interventions
GAD

Conditions studied

Sleep Health — all drugs for Sleep Health →

Sponsor

NYU Langone Health — full company profile →

Who can join

Adults 18 to 99, any sex, with Sleep Health. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A pilot study that seeks to develop a set of typologies of users of mobile sleep tracking technologies, and optimal sleep health educational strategies among users of mobile wearable technologies that track sleep.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Sleep Health

Currently open trials in the same condition.

NCT06348082 — Project Women's Insomnia Sleep Health Equity Study (WISHES) · NA · recruiting
NCT06627504 — Type 1 Diabetes REst for Metabolic Health · NA · recruiting
NCT07359612 — Improving Sleep Health Through Magnesium Supplementation · NA · active not recruiting

Other NYU Langone Health trials

Trials by the same sponsor.

NCT07214519 — Permanent Supportive Housing Overdose Prevention-2 Study · NA · not yet recruiting
NCT05558267 — Potassium Containing Salt-Substitute in Hemodialysis-Dependent End Stage Kidney Disease · NA · not yet recruiting
NCT06637852 — Sexual and Urinary Function Improvement for Cancer Survivors · NA · not yet recruiting
NCT06236087 — Overdose Prevention Centers and Behavioral Health · not yet recruiting
NCT06462027 — Packed Red Blood Cell Transfusion During Cardiac Arrest · Phase 1 · suspended

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03489460 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by NYU Langone Health
Last refreshed: 30 January 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03489460.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing